Technology AirLog⁶: Primary Clinical Protection

PREMISE: Innovative digital medical devices with clinical protection

We are pleased to present technology AirLog⁶ Permanent clinical protection in the air as the first defense ,of the human person, by molecular pathologies generated by indoor pollution .

Technology includes some "V80" programmable digital devices based on the number of people to be protected for the purposes of a qualitative efficacy in order to avoid waste waste.

The formulated AirLog⁶ It is equipped with translational research for new technologies in medicine and surgery (Uni Pisa) In addition to a previous certification of WHO guidelines in critical environments in class III, as bacteriology workshops.

Consisting of known principles , Present in the international pharmacopoeia and pharmaceutical handments : propanolo 1 and 2 Clorexidina f.m. Cetrimide bromide over a synthesis (patent F.V.) Therefore it performs a synergy of action on large ghosts of microorganisms identifiable on the literature Pierrel and microbiological scientific bibliography , Beyond provision of test relationships, in Accredia laboratories, where the times of action and regulation of the same devices are identified.

  The determination of the useful value of presence in the air (0,3 g/h a persona ) has been determined through stechiometric calculations and in vivo tests in intensive critical health environments corresponding to an administration type of effective antibiotic therapy.